Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aleksei A. Stepanenko
Observed names:
A. A. Stepanenko,
A.A. Stepanenko,
Aleksei Stepanenko,
Alexey A. Stepanenko,
Stepanenko, Aleksei
Institutions:
Pirogov Russian National Research Medical University,
Ministry of Health of the Russian Federation,
Federal Medical Research Centre for Psychiatry and Narcology
Observed institutions:
National Academy of Sciences of Ukraine,
Pirogov Russian National Research Medical University,
Ministry of Health of the Russian Federation,
Federal Medical Research Centre for Psychiatry and Narcology,
Institute of Molecular Biology and Genetics
ORCID:
0000-0003-3821-6846
Observed ORCID:
0000-0003-3821-6846
OpenAlex ID:
A5004763915
HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution
2015
·
A.A. Stepanenko
, V.V. Dmitrenko
·
Gene
·
405
Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability
2015
·
A.A. Stepanenko
, V.V. Dmitrenko
·
Gene
·
380
Transient and stable vector transfection: Pitfalls, off-target effects, artifacts
2017
·
Aleksei A. Stepanenko
, Henry H. Heng
·
Mutation Research/Reviews in Mutation Research
·
141
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
2018
·
Aleksei Stepanenko
, Vladimir Chekhonin
·
Cancers
·
65
PDF
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
2016
·
Aleksei A. Stepanenko
, Svitlana V. Andreieva
, et al.
·
Cancer Cell International
·
63
PDF
Antagonistic functional duality of cancer genes
2013
·
A.A. Stepanenko
, Y.S. Vassetzky
, et al.
·
Gene
·
59
Immortalization and malignant transformation of Eukaryotic cells
2012
·
A. A. Stepanenko
, V. M. Kavsan
·
Cytology and Genetics
·
53
Systemic and local immunosuppression in glioblastoma and its prognostic significance
2024
·
Aleksei A. Stepanenko
, Anastasiia O. Sosnovtseva
, et al.
·
Frontiers in Immunology
·
50
PDF
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX
2018
·
Aleksei A. Stepanenko
, Vladimir P. Chekhonin
·
Virus Research
·
48
Karyotypically distinct U251, U373, and SNB19 glioma cell lines are of the same origin but have different drug treatment sensitivities
2014
·
Alexey A. Stepanenko
, Vadym M. Kavsan
·
Gene
·
43
Step-wise and punctuated genome evolution drive phenotype changes of tumor cells
2014
·
Aleksei Stepanenko
, Svitlana Andreieva
, et al.
·
Mutation research. Fundamental and molecular mechanisms of mutagenesis
·
38
On the Critical Issues in Temozolomide Research in Glioblastoma: Clinically Relevant Concentrations and MGMT-independent Resistance
2019
·
Aleksei A. Stepanenko
, Vladimir P. Chekhonin
·
Biomedicines
·
31
PDF
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
2021
·
Aleksei A. Stepanenko
, Anastasiia O. Sosnovtseva
, et al.
·
Molecular Therapy — Oncolytics
·
30
PDF
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
2012
·
A. A. Stepanenko
, V. M. Kavsan
·
Biopolymers and Cell
·
26
PDF
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
2024
·
Aleksei A. Stepanenko
, Anastasiia O. Sosnovtseva
, et al.
·
Frontiers in Immunology
·
25
PDF
A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
2021
·
Aleksei A. Stepanenko
, Anastasiia O. Sosnovtseva
, et al.
·
Scientific Reports
·
24
PDF
A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy
2018
·
Aleksei A. Stepanenko
, Vladimir P. Chekhonin
·
Gene
·
22
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?
2022
·
Victor A. Naumenko
, Aleksei A. Stepanenko
, et al.
·
Molecular Therapy — Oncolytics
·
21
PDF
mTOR inhibitor temsirolimus and MEK1/2 inhibitor U0126 promote chromosomal instability and cell type-dependent phenotype changes of glioblastoma cells
2015
·
A.A. Stepanenko
, S.V. Andreieva
, et al.
·
Gene
·
20
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
2022
·
Victor A. Naumenko
, Daniil A. Vishnevskiy
, et al.
·
Biomedicines
·
17
PDF
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury
2022
·
Anastasiia O. Sosnovtseva
, Olga V. Stepanova
, et al.
·
Frontiers in Pharmacology
·
9
PDF
Study of the Therapeutic Efficiency of Transduced Olfactory Ensheathing Cells in Spinal Cord Cysts
2021
·
Olga V. Stepanova
, Anastasia D. Voronova
, et al.
·
Stem Cells and Development
·
8
Expression of genes belonging to the IGF-system in glial tumors
2011
·
V. V. Dmitrenko
, V. M. Kavsan
, et al.
·
Cytology and Genetics
·
6
Comparison of the L3-23K and L5-Fiber Regions for Arming the Oncolytic Adenovirus Ad5-Delta-24-RGD with Reporter and Therapeutic Transgenes
2025
·
Aleksei A. Stepanenko
, Anastasiia O. Sosnovtseva
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
From reverse transcription to human brain tumors
2013
·
V. V. Dmitrenko
, S. S. Avdieiev
, et al.
·
Biopolymers and Cell
·
2
PDF
Show more works
View as search
Works count:
45
Citation count:
1,591
H-index:
19
I10-index:
20
Year
Topic
Type